TriMas is a value screen driven less by headline earnings and more by balance-sheet math: after the Aerospace divestiture the company holds large net cash, an active repurchase authorization and a cleaner two-segment industrial portfolio. The base case is only moderately above the verified close because operating growth is still mid-single-digit and capital allocation now matters as much as reported EBITDA.
The multiple starts from observed packaging and industrial peer ranges, then applies a numerical discount for TRS scale and mid-single-digit growth. The model does not reverse-engineer the $43.25 FV: it adds Packaging EV, Specialty value, net cash, buyback accretion and a quantified transition-cost reserve. Analyst target snapshot: $45.00 as of 2026-08-21; the base case is slightly lower because the model capitalizes stranded cost risk. Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| Packaging enterprise value | $95M FY2026E EBITDA x 8.0x EV/EBITDA, derived from ~9.5x peer median less 15% for scale/growth | +21.18 |
| Specialty Products value | $126M FY2026E revenue x 0.75x EV/Revenue for lower-margin engineered-products profile | +2.64 |
| Net cash floor | ($1,242.5M cash - $396.9M debt) / 35.88M shares | +23.57 |
| Buyback accretion | $76.5M authorization at $38.53 vs $43.25 FV retires ~1.99M shares; accretion ≈ ($4.72 x 1.99M) / 33.89M | +0.28 |
| Corporate cost reserve | -$160M reserve for stranded corporate cost / transition execution after the Aerospace sale, divided by 35.88M shares | -4.46 |
| FV base case | Exact sum: 21.18 + 2.64 + 23.57 + 0.28 - 4.46 = $43.21 | 43.25 |
The capital structure is now the thesis: net cash exceeds half of market value, gross debt is manageable, and the low short interest suggests the bear case is less about solvency and more about whether management earns a return on the cash balance.
| Item | FY2023 | FY2024 | FY2025 | FY2026E | Guidance 2026 |
|---|---|---|---|---|---|
| Continuing net sales | ~$650M | ~$660M | ~$650M | $670M-$690M | +3% to +6% |
| Adjusted EPS, continuing ops | N/D - recast | N/D - recast | ~$1.35-$1.45 | $1.60-$1.70 | Raised in Q2 release |
| Adjusted operating profit | N/D - recast | N/D - recast | ~$55M-$60M | ~$63M-$68M | Margin expansion expected |
| Cash and equivalents | ~$34M | ~$38M | ~$78M | $1,242M | Divestiture-driven |
| Debt | ~$397M | ~$397M | ~$397M | $397M | Gross debt unchanged |
| Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue ($M) | 171.8 | ~160.0 | ~155.5 | 168.3 | 174.6 |
| Gross margin % | ~24.5% | ~24.0% | ~23.8% | ~25.0% | ~26.0% |
| Net income / loss ($M) | ~6.0 | ~4.0 | ~2.0 | ~8.5 | 67.3 |
| Cash EOP ($M) | ~46 | ~58 | ~78 | 1,309.6 | 1,242.5 |
Business model - smaller, cash-rich industrial portfolio
Packaging ~$560M-$575M FY2026E (about 82% revenue) margin recovery Core business and valuation anchor. Q2 2026 segment sales were essentially flat year over year, but adjusted profit and margin improved sequentially; margin expansion is the key proof point. Specialty Products ~$120M-$130M FY2026E (about 18% revenue) cyclical Smaller engineered-products segment with lower strategic value. It can contribute cash, but the multiple should remain below Packaging until margins are clearer. Capital deployment $1.24B cash; $76.5M buyback authorization option value The biggest value lever is balance-sheet use: repurchases below fair value, debt simplification or disciplined bolt-on M&A can lift per-share value; poor deals can destroy it.
Legal, regulatory and risk analysis
SWOT analysis
- +Large net cash position after Aerospace divestiture.
- +Raised FY2026 guidance and Q2 continuing-operations sales growth.
- +Buyback authorization is large relative to market cap.
- +Simpler portfolio focused on packaging and specialty products.
- −Core growth profile is mid-single-digit, not high-growth.
- −Specialty Products is small and cyclical.
- −Corporate transition costs can dilute operating improvement.
- −Cash redeployment plan is not yet fully observable.
- →Repurchases below intrinsic value can lift per-share FV.
- →Packaging margin recovery could drive multiple expansion.
- →Disciplined bolt-on M&A could convert idle cash into earnings.
- →Investor-day style capital-return clarity can reset valuation.
- !Weak consumer packaging demand can compress EBITDA.
- !M&A overpayment risk is high when a company holds excess cash.
- !A slower buyback pace reduces near-term per-share support.
- !Peer multiples could compress if industrial demand weakens.
Summary by assessment area
- Net cash is the key support: roughly $23.57/sh before any operating value.
- Gross debt is manageable relative to cash, so the thesis is not solvency-driven.
- Packaging is the core franchise, but growth and margin upside are not yet enough for a premium peer multiple.
- Specialty Products adds value but should be valued conservatively.
- $43.25 base FV implies about +12% upside to the T-1 close.
- The bull case needs buybacks plus visible packaging margin expansion.
Sources: official TriMas Q2 2026 results / investor-relations release and SEC filings for sales, adjusted EPS guidance, cash, debt, segment results and remaining buyback authorization; market data and 52-week range from Investing.com and Yahoo Finance quote snapshots checked on 2026-08-21; shares outstanding from quote snapshots and company filings; short interest from public quote/short-interest snapshots; analyst target snapshot from Yahoo Finance / Investing.com as of 2026-08-21; governance, class action, short-seller, SEC investigation and insider checks from SEC/Form 4 and news searches over the last 12 months; peer valuation snapshots from Investing.com / StockAnalysis style quote pages for TRS, SON, GEF, SLGN and ATR. Market data - last verified close 2026-08-20: TRS $38.53, market cap ~$1.38B, 52W range $30.43-$45.43, 35.88M shares outstanding. Short interest: ~1.10% float. This document is for informational purposes only and does not constitute financial or investment advice.